ABCL Latest Press Releases

-- June 17, 2026 --

Jazz Pharmaceuticals and AbCellera Announce Collaboration to Discover Next-Generation T-cell Engaging Multispecific Antibodies Business Wire 7:00 AM

-- June 5, 2026 --

AbCellera Appoints Dr. Victor Sandor to its Board of Directors Business Wire 9:00 AM

-- May 11, 2026 --

AbCellera Reports Q1 2026 Business Results & Announces Positive Interim Phase 1 Clinical Data for ABCL635 Business Wire 4:05 PM

-- May 7, 2026 --

AbCellera to Present at Upcoming Investor Conferences in May and June 2026 Business Wire 4:05 PM

-- April 20, 2026 --

AbCellera to Highlight Phase 1 Clinical Data for ABCL635 During Upcoming First Quarter 2026 Earnings Call Business Wire 9:00 AM

-- April 1, 2026 --

AbCellera to Report First Quarter 2026 Financial Results on May 11, 2026 Business Wire 4:05 PM

-- February 24, 2026 --

AbCellera Reports Full Year 2025 Business Results Business Wire 4:05 PM

-- February 11, 2026 --

AbCellera to Present at Upcoming Investor Conferences in March and April 2026 Business Wire 4:05 PM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software